National Institute of General Medical Sciences (NIGMS)
Age
21–69
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
Breast cancer diagnosis
Received surgery +/- chemotherapy +/- radiation for treatment of a Stage I, II or III breast cancer. Ongoing treatment with monoclonal antibodies and/or anti-estrogen therapy is acceptable
Completion of initial therapy 6 weeks prior to study initiation
BMI of 27-45 kg/m\^2
You may not be if
Medical conditions that limit food choices such as celiac sprue or inflammatory bowel disease
Inability to walk on flat ground (or a treadmill) at 2.5 mph for 5 minutes
Age \<21 and \>70
Presence of body metal
Psychotic or central nervous system impairment that would limit compliance with study requirements, including dementia
Evidence of metastatic disease
Symptomatic heart disease (chest pain or equivalent with activity)
Exercise limiting pulmonary disease or need for oxygen to exercise
Participants with an active neurologic disorder that affects the central nervous system, including seizures, and Parkinson's disease
Weight loss of \>10 lbs in the previous 6 months
Participation in \> 150 minutes of moderate intensity activity by self report, unless activity level by accelerometer is less than 150 minutes of moderate intensity activity
Clareo Health | Behavioral Weight Loss and Exercise After Treatment (BEAT)
